斯迪克(300806.SZ):子公司擬4.06億元投資偏光片保護膜項目
格隆匯 6 月 30日丨斯迪克(300806.SZ)公佈,為強化公司功能性膠帶生產能力,進一步優化產品結構並提高公司的綜合競爭力和盈利能力。公司全資子公司斯迪克新型材料(江蘇)有限公司(“斯迪克江蘇”)擬以自籌資金投資偏光票保護膜建設項目。該項目建設總投資預計為約4.06億元,建設內容包括裝修工程、設備購置及安裝及室外配套工程,預計將新增生產線4條。項目建成後,可達到年生產偏光片保護膜17107.20萬平方米,項目計劃分3年達產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.